A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma
Year: 2020
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Institutions: Sarcoma Oncology Center, Montefiore Medical Center, City Of Hope National Medical Center, Comprehensive Cancer Centers of Nevada, University of California, Los Angeles, Ronald Reagan UCLA Medical Center, UCLA Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, NanoCarrier (Japan), Duke Medical Center, Duke Cancer Institute
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W3022598503